NSEScheme of Arrangement2 Jul 2026 · 2 Jul 2026, 06:13 pm
Scheme of Arrangement
GSP Crop Science Limited · GSPCROP
✦ AI SummaryM&A
GSP Crop Science Limited has informed the Exchange about Scheme of Arrangement Amongst Rajdhani Petrochemicals Private Limited and GSP Crop Science Limited.
Analysis Scores
Earnings Impact5/10
Growth Catalyst8/10
Governance Concern2/10
Regulatory Risk4/10
Balance Sheet Risk6/10
Liquidity Impact7/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
GSP Crop Science Limited has informed the Exchange about Scheme of Arrangement
Attachments (1)
📄pdf
Download →
GSP123_02072026181226_OutcomeBM02072026.pdf
View document text
Date: July 2, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza,
Dalal Street, Plot No. C/1, G Block,
Mumbai – 400 001 Bandra Kurla Complex, Bandra (East),
Mumbai – 400 051
Scrip Code: 544733 Trading Symbol: GSPCROP
Dear Sir/Madam,
Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015.
With reference to the captioned subject and other applicable provision, if any, of SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing
Regulations"), read with the applicable provisions of the SEBI Master Circular dated
January 30, 2026, this is to inform you that the meeting of the Board of Directors of the
Company held today i.e., Thursday, July 2, 2026, has, inter-alia, considered and approved
the following:
Subject to requisite approvals/consents, the Scheme of Arrangement Amongst Rajdhani
Petrochemicals Private Limited (“Transferor Company Or RPPL”), GSP Intermediates
Private Limited (“Demerged Company Or GIPL”) And GSP Crop Science Limited (“The
Company” Or “Transferee Company” Or “Resulting Company” Or “GSP”) and their
Respective Shareholders/Creditors Under Section 230 To 232 and other applicable
provisions of the Companies Act, 2013. The salient features of the proposed Scheme,
inter alia, are given as under:
a) The Appointed Date of the Scheme would be 1st April, 2026.
b) The entire assets and liabilities of RPPL and of the Demerged Undertaking of GIPL
to be transferred to and recorded by the Company at their carrying values.
c) The entire share capital of RPPL and GIPL is held by the Company. Upon the
Scheme becoming effective, no equity shares or other security (ies) of the
Company shall be allotted in lieu or exchange of the holding of the Company in
RPPL and GIPL. Further, equity shares held by the Company in RPPL shall stand
cancelled on the Effective Date without any further act, instrument or deed.
The relevant details required under Regulation 30 of the SEBI Listing Regulations read
with SEBI Master Circular SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-
POD2/I/3762/2026 dated January 30, 2026, annexed herewith as ‘Annexure A’.
The Board Meeting commenced at 4:00 P.M. and concluded at 5:30 P.M. (IST).
This intimation is also being uploaded on the Company’s website at
https://www.gspcrop.in.
You are requested to take the same on your records.
Thanking you,
Yours faithfully,
For GSP Crop Science Limited
Kamleshbhai D Patel
Company Secretary & Compliance Officer
M. No. FCS 8018
Encl: as above
ANNEXURE-A
The relevant details required under Regulation 30 of SEBI LODR Regulation read with
SEBI Master Circular SEBI HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January
30, 2026 are as below:
For Amalgamation of Rajdhani Petrochemicals Private Limited (“Transferor
Company” or “RPPL”) with GSP Crop Science Limited (“Transferee Company” or
“GSP”)
Sr. Particulars Description
1 Name of the entity(ies) Rajdhani Petrochemicals Private Limited
forming part of the (Transferor Company) (as on March
amalgamation/merger, 31,2026)
details in brief such as, size, Particulars INR in Lakh
turnover etc Paid up Capital 10.00
Net Worth 6453.73
Total Income 12450.90
GSP Crop Science Limited (Transferee
Company) (as on March 31,2026)
Particulars Amount (INR)
Paid up Capital 4651.875
Net Worth 73446.6
Total Income 162760.8
2 Whether the transaction Yes, the Transferor Company is the Wholly
would fall within related party Owned Subsidiary of the Transferee
transactions? If yes, whether Company and as such the said Companies
the same is done at “arm’s are related party to each other.
length
However, the said transaction shall not attract
compliance with the requirements of Section
188 of the Companies Act, 2013 pursuant to
the clarifications given by the Ministry of
Corporate Affairs, vide its General Circular
No.30/2014 dated 17th July, 2014.
Further, pursuant to Regulation 23(5)(b) of the
SEBI Listing Regulations, the related party
transaction provisions are not applicable to
the proposed Scheme and the Scheme is also
exempt from the provisions of SEBI Master
Circular No. SEBI/HO/CFD/POD-
/P/CIR/2023/93 dated June 20, 2023.
3 Area of business of the The Transferor Company is engaged in the
entity(ies) business of production and sale of
agrochemical products.
The Transferee Company is engaged in the
business of production and sale of
agrochemical products.
4 Rationale for amalgamation/ i. Streamlining of the corporate structure
merger and consolidation of assets and
liabilities of the Transferor Company
with the Transferee Company, leading
to synergies of operations and resulting
in the expansion and long-term
sustainable growth, which will enhance
value for various stakeholders of the
Transferee Company;
ii. The Transferee Company will have the
benefit of combined resources, market
share, scale, efficiency, combined net-
worth, combined employee base,
reserves, investments, and other
assets, manpower, consolidated pool
of finances, including optimization of
borrowing costs, larger size,
consolidation of operations, and future
opportunities;
iii. Simplification of corporate structure by
reducing the multiplicity of legal and
regulatory compliances through
rationalization;
iv. Reduction of administrative
responsibilities, multiplicity of records
and legal and regulatory compliances,
cost savings and elimination of
duplicate expenses; and
v. Achieve optimal and efficient utilization
of capital, enhance operational and
management efficiencies.
5 In case of cash consideration The entire share capital of the Transferor
– amount or otherwise share Company is held by the Company. Upon the
exchange ratio Scheme becoming effective, no equity shares
of the Company shall be allotted in lieu or
exchange of the holding of the Company in the
Transferor Company and accordingly, equity
shares held by the Company in the Transferor
Company shall stand cancelled on the
Effective Date without any further act,
instrument, or deed. Further, there is no cash
consideration involved in the Scheme.
6 Brief details of change in There will be no change in the equity
shareholding pattern (if any) shareholding pattern of the listed entity
of listed entity pursuant to the Scheme, as no shares are
required to be issued by the Company in
connection with the Scheme of Arrangement.
For the De-Merger of the Manufacturing Undertaking (“Demerged Undertaking”) of GSP
Intermediates Private Limited (“Demerged Company” or “GIPL”) into GSP Crop Science Limited
(“Resulting Company” or “GSP”)
Sr. Particulars Description
1 Brief details of the division(s) Manufacturing Undertaking (“Demerged
to be demerged Undertaking”) of GSP Intermediates Private
Limited (“Demerged Company) is engaged in
the business of production and sale of
agrochemical products.
2 Turnover of the demerged Turnover for FY 2025-26 of the demerged
division and as percentage undertaking of GIPL is 2,825.94 (INR in
to the total turnover of the Lakhs)
listed entity in the
immediately preceding Further, the Scheme involves demerger from
financial year / based on unlisted wholly owned subsidiary into the
financials of the last financial parent listed company and hence details
year regarding percentage to the total turnover of
the listed entity are not applicable in the
instant case.
3 Rationale for demerger i. Consolidation of assets and liabilities of
the Demerged Undertaking of the
Demerged Company with the
Company, leading to synergies of
operations and resulting in the
expansion and long-term sustainable
growth, which will enhance value for
various stakeholders of the Company;
ii. The Company will have the benefit of
combined resources, market share,
scale, efficiency, combined net-worth,
combined employee base, reserves,
investments, and other assets,
manpower, consolidated pool of
finances, including optimization of
borrowing costs, larger size,
consolidation of op
[Showing first 8,000 characters — download PDF for full document]